Gene therapy holds great promise for the treatment of various genetic diseases. However, successes in expressing transgenes in vitro are often not reproduced when transferred in vivo. It became clear in several studies that immune responses to the vector and/or transgene product heavily influence in vivo gene therapy oerformance. The Immunology Core has focused its efforts on studying the natural existing T and B cell mmunity to Adenovirus (AdV) and Adeno-associated virus (AAV) in human and non human primates (NHPs). We have also .centered our studies on vector and transgene specific T and B cell responses after systemic or local administration of various rAAV and rAdV serotypes carrying different transgenes in NHP models. This will help us to determine if rAAV and rAdV administration can re-activate existing or induce new T cell responses to the vector or the transgene product, and whether these have any effect on the outcome of the gene therapy and the health of the patient. Moreover we studied the activation of hCFTR-specific T cells in cystic fibrosis mice following gene transfer. The mission of the Immunology Core is to assist Center Participants in developing and conducting assays to evaluate cell mediated and humoral immune responses after gene therapy treatment in small and large animal models including mice, dogs, non human primates and humans. In all these studies we isolated lymphocytes from blood, liver, intestine, primary and secondary lymphoid organs and characterized the T cell response by ex vivo and cultured IFNy ELISPOT, lymphoproliferation assay, in vivo CTL assay, and polychromatic flow cytometric analysis (5-11 colors) of antigen specific T cells. B cell responses were characterized measuring total and neutralizing antibodies in serum and mucosal secretions.

Public Health Relevance

Undesirable immune response to viral vectors and therapeutic gene products could affect the outcome of gene therapy. Immunology Core is well-equipped and determined to investigate this problem in pre-clinical and clinical gene therapy studies.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
United States
Zip Code
Baek, Jeong-In; Choi, Soo Young; Chacon-Heszele, Maria F et al. (2014) Expression of Drosophila forkhead transcription factors during kidney development. Biochem Biophys Res Commun 446:15-7
Adam, Virginie S; Crosariol, Marco; Kumar, Sachin et al. (2014) Adeno-associated virus 9-mediated airway expression of antibody protects old and immunodeficient mice against influenza virus. Clin Vaccine Immunol 21:1528-33
Xiao, Yan; Nagai, Yasuhiro; Deng, Guoping et al. (2014) Dynamic interactions between TIP60 and p300 regulate FOXP3 function through a structural switch defined by a single lysine on TIP60. Cell Rep 7:1471-80
Chacon-Heszele, Maria F; Zuo, Xiaofeng; Hellman, Nathan E et al. (2014) Novel MAPK-dependent and -independent tubulogenes identified via microarray analysis of 3D-cultured Madin-Darby canine kidney cells. Am J Physiol Renal Physiol 306:F1047-58
Mays, Lauren E; Wang, Lili; Lin, Jianping et al. (2014) AAV8 induces tolerance in murine muscle as a result of poor APC transduction, T cell exhaustion, and minimal MHCI upregulation on target cells. Mol Ther 22:28-41
Nagai, Y; Limberis, M P; Zhang, H (2014) Modulation of Treg function improves adenovirus vector-mediated gene expression in the airway. Gene Ther 21:219-24
O'Neill, S M; Hinkle, C; Chen, S-J et al. (2014) Targeting adipose tissue via systemic gene therapy. Gene Ther 21:653-61
Huang, Liwei; Lipschutz, Joshua H (2014) Cilia and polycystic kidney disease, kith and kin. Birth Defects Res C Embryo Today 102:174-85
Myint, Melissa; Limberis, Maria P; Bell, Peter et al. (2014) In vivo evaluation of adeno-associated virus gene transfer in airways of mice with acute or chronic respiratory infection. Hum Gene Ther 25:966-76
Bryant, Laura M; Christopher, Devin M; Giles, April R et al. (2013) Lessons learned from the clinical development and market authorization of Glybera. Hum Gene Ther Clin Dev 24:55-64

Showing the most recent 10 out of 206 publications